Literature DB >> 8044038

Duration of illness and neuropsychological performance in asymptomatic HIV infection.

R A Bornstein1, H A Nasrallah, M F Para, C C Whitacre, R J Fass.   

Abstract

The relationship between duration of illness and neuropsychological performance was examined in 25 asymptomatic HIV-infected men with an estimated date of seroconversion. Mean duration of illness was approximately 2 years. After controlling for CD4 level at the time of neuropsychological examination, duration of illness was correlated with measures of visual attention, mental flexibility, dexterity, auditory information processing, and response fluency, as well as an overall measure of neuropsychological performance. Although these patients performed within normal limits, these data suggest that duration of infection may be related to subtle alterations in neuropsychological performance. These results are discussed with regard to possible mechanisms that implicate gradual accumulation of neurotoxins.

Entities:  

Mesh:

Year:  1994        PMID: 8044038     DOI: 10.1176/jnp.6.2.160

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  4 in total

Review 1.  Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research.

Authors:  Lisa R Norman; Michael Basso; Anil Kumar; Robert Malow
Journal:  Curr Drug Abuse Rev       Date:  2009-05

Review 2.  Neuropsychiatric manifestations of HIV infection and AIDS.

Authors:  Benoit Dubé; Tami Benton; Dean G Cruess; Dwight L Evans
Journal:  J Psychiatry Neurosci       Date:  2005-07       Impact factor: 6.186

3.  Neurocognitive effects of HIV, hepatitis C, and substance use history.

Authors:  Kathryn N Devlin; Assawin Gongvatana; Uraina S Clark; Jesse D Chasman; Michelle L Westbrook; Karen T Tashima; Bradford Navia; Ronald A Cohen
Journal:  J Int Neuropsychol Soc       Date:  2011-12-02       Impact factor: 2.892

4.  Neuropsychological functioning in HIV-positive African-American women with a history of drug use.

Authors:  K I Mason; A Campbell; P Hawkins; S Madhere; K Johnson; R Takushi-Chinen
Journal:  J Natl Med Assoc       Date:  1998-11       Impact factor: 1.798

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.